Etraxa SL 250mg/125mg Injection
Marketer
Zubit Lifecare
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Etraxa SL 250mg/125mg Injection
Combiflox Injection (250mg/125mg) is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thus halting infection progression. Administration must be solely under a physician's guidance; strict adherence to the prescribed schedule is crucial. Complete the full treatment course, regardless of symptom improvement; premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Seek immediate medical care for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing, avoid driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration contribute to faster recovery. Monitoring may involve laboratory tests to assess the medication's impact.
Primary Ingredients of Etraxa SL 250mg/125mg Injection
No information provided. A rephrased version cannot be created.
Uses of Etraxa SL 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Etraxa SL 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Etraxa SL 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Etraxa SL 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Etraxa SL 250mg/125mg Injection works:
Ceftriaxone/Sulbactam 250mg/125mg (Etraxa SL Injection) combines a cephalosporin antibiotic (Ceftriaxone) with a beta-lactamase inhibitor (Sulbactam). Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their growth and survival. Sulbactam's role is to counter bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Etraxa SL 250mg/125mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Etraxa SL 250mg/125mg is typically viewed as safe for use during gestation. Preclinical trials in animals have revealed minimal or no harmful consequences for the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Etraxa SL 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Etraxa SL 250mg/125mg Injection can cause drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if these side effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Etraxa SL 250mg/125mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The injectable medication Etraxa SL 250mg/125mg requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Seek medical advice before use. Dosage alteration for Etraxa SL 250mg/125mg Injection is unnecessary in patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Etraxa SL 250mg/125mg Injection :
Should you inadvertently skip a dose of the Etraxa SL 250mg/125mg Injection, seek medical advice.
Facts to Know About Etraxa SL 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently